GlassScriptPhysician profile
Alexander K Powers
NPI 1134397714
$1,713,404.52
in general payments reported to CMS, 2019-2025
27 companies · $75K in 2025
The $75K reported for 2025 was more than what 96% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380K · 2020: $235K · 2021: $117K · 2022: $321K · 2023: $335K · 2024: $251K · 2025: $75K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $622K · Consulting Fee: $29K · Travel and Lodging: $4,877 · Food and Beverage: $4,661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $622,205.97 |
| Consulting Fee | $28,850.00 |
| Travel and Lodging | $4,876.80 |
| Food and Beverage | $4,661.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,422,831.03 | 2019-2024 | Serrato, Airo, Ascential Acp 1 |
| Globus Medical, INC. | $270,820.91 | 2019-2025 | Hedron, Hedron C, Hedron Ic |
| Biedermann Motech, INC. | $7,769.71 | 2019-2022 | |
| Medacta USA, INC. | $6,560.55 | 2024-2025 | Myspine, Must, Nextar Spine Platform |
| Medtronic, INC. | $1,535.66 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Orthofix Medical, INC. | $926.36 | 2019-2025 | Spinal-Stim |
| Cerapedics INC. | $424.68 | 2022 | |
| Boston Scientific Corporation | $405.44 | 2019-2024 | |
| Medtronic USA, INC. | $354.25 | 2019-2020 | |
| Nuvasive, INC. | $333.23 | 2019-2023 | Xlif, Simplify Cervical Artificial Disc |
| Si-Bone, INC. | $287.34 | 2022-2025 | |
| Providence Medical Technology, INC. | $273.94 | 2025 | |
| Abbott Laboratories | $175.28 | 2022 | |
| Intrinsic Therapeutics | $172.75 | 2021-2025 | Barricaid Acd (Annular Closure Device) |
| Carlsmed, INC. | $92.42 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Restor3d, INC. | $74.68 | 2022 | |
| Seaspine Orthopedics Corporation | $64.92 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $52.58 | 2022 | |
| Arteriocyte Medical Systems, INC. | $47.27 | 2023 | Magellan |
| Augmedics INC. | $43.22 | 2022-2025 | Xvision |
| Depuy Synthes Sales INC. | $37.19 | 2022 | |
| Sk Life Science, INC. | $27.47 | 2025 | |
| Centinel Spine, LLC | $26.20 | 2023 | Prodisc L |
| Elevation Spine, INC. | $20.80 | 2025 | |
| Alphatec Spine, INC | $18.77 | 2023 | Other - Miscellaneous |
| Djo, LLC | $14.50 | 2024 | Cmf |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.